Copyright
©The Author(s) 2021.
World J Transplant. Jun 18, 2021; 11(6): 187-202
Published online Jun 18, 2021. doi: 10.5500/wjt.v11.i6.187
Published online Jun 18, 2021. doi: 10.5500/wjt.v11.i6.187
Sr No | Issues | Remarks |
1 | All available prognostic scoring systems have limited accuracy | Error of both commission and omission can happen |
2 | Heterogeneity in the studies evaluating prognosis in ALF: Variations in the definitions of ALF, etiologies, & management protocol | The heterogeneity makes it difficult to compare the results between studies and draw a uniform conclusion |
3 | Survival rates of ALF patients on medical treatment have improved but models used are still the old ones | Reduced performance of old models (e.g., KCC) have been noted in the newer studies compared to the old ones |
4 | Many studies have considered and analyzed transplanted patients as ‘non-survivors’ | This may falsely elevate the positive predictive value of a prognostic, increasing the risk of unnecessary LT in some patients |
5 | Lack of reproducibility and validation studies for many prognostic scores | A model cannot be implemented in the clinical practise without adequate validation studies |
6 | Dynamic models are better than models based on baseline parameters, but critical time at which decision should be made is not clear | A very late decision may results in loss of opportunity to transplant, and very early decision may lead to unnecessary LT |
7 | Many models have included non-ideal parameters, such as factor V, apoptotic markers, monocyte HLA, etc | These markers are not routinely available and their measurement involve additional investigations and cost |
8 | Some prognostic markers, such as serum bilirubin and INR, are subject to laboratory variations | This may cause error in selection of LT candidates |
9 | Inclusion of advanced HE in some prognostic models | HE is subjective markers, and advanced HE is usually a late feature of ALF |
10 | Inclusion of CE in prognostic models | CE is difficult to diagnosed clinically, and a clinically overt CE is usually a late feature |
- Citation: Kumar R, Anand U, Priyadarshi RN. Liver transplantation in acute liver failure: Dilemmas and challenges. World J Transplant 2021; 11(6): 187-202
- URL: https://www.wjgnet.com/2220-3230/full/v11/i6/187.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i6.187